NCT02142127View on ClinicalTrials.gov

Mass Balance Study of 14C-labelled GFT505 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

April 30, 2015

Conditions
Healthy
Interventions
DRUG

14C-labelled GFT505 120 mg

Trial Locations (1)

2060

SGS Life Science Services, Antwerp

Sponsors

Lead Sponsor

Genfit
All Listed Sponsors
collaborator

SGS Life Sciences, a division of SGS Belgium NV

OTHER

lead

Genfit

INDUSTRY

NCT02142127 - Mass Balance Study of 14C-labelled GFT505 in Healthy Volunteers | Biotech Hunter | Biotech Hunter